Hanshow Technology
301275
Yong Jie New Material
603271
ZZT
873726
4
BEOKA
870199
5
Geovis Insighter Technology
920116
US Stock MarketDetailed Quotes
CGEM Cullinan Therapeutics
- 8.150
- -0.560-6.43%
Close Mar 10 16:00 ET
- 8.250
- +0.100+1.23%
Pre 08:11 ET
476.88MMarket Cap-2.93P/E (TTM)
8.650High8.090Low606.35KVolume8.550Open8.710Pre Close5.05MTurnover1.56%Turnover RatioLossP/E (Static)58.51MShares30.18952wk High0.81P/B317.69MFloat Cap7.90052wk Low--Dividend TTM38.98MShs Float59.850Historical High--Div YieldTTM6.43%Amplitude7.300Historical Low8.333Avg Price1Lot Size
Cullinan Therapeutics Key Stats
Quarterly+Annual
YOY
| (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating revenue | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Cost of revenue | ||||||||||
| Gross profit | ||||||||||
| Operating expense | 3.29%196.92M | 21.02%55.05M | 9.04%48.86M | 33.03%50.03M | -31.50%42.99M | 44.28%190.65M | 39.49%45.49M | 50.52%44.8M | 1.34%37.61M | 92.17%62.76M |
| Selling and administrative expenses | 27.12%54.02M | 36.84%14.56M | 21.55%13.35M | 34.80%13.77M | 15.79%12.34M | 5.73%42.49M | -5.76%10.64M | 8.88%10.98M | -4.50%10.21M | 31.26%10.66M |
| -General and administrative expense | 27.12%54.02M | 36.84%14.56M | 21.55%13.35M | 34.80%13.77M | 15.79%12.34M | 5.73%42.49M | -5.76%10.64M | 8.88%10.98M | -4.50%10.21M | 31.26%10.66M |
| Research and development costs | -3.55%142.9M | 16.20%40.49M | 4.98%35.51M | 32.38%36.26M | -41.17%30.65M | 61.13%148.16M | 63.44%34.85M | 71.85%33.82M | 3.71%27.39M | 112.32%52.1M |
| Operating profit | -3.29%-196.92M | -21.02%-55.05M | -9.04%-48.86M | -33.03%-50.03M | 31.50%-42.99M | -44.28%-190.65M | -39.49%-45.49M | -50.52%-44.8M | -1.34%-37.61M | -92.17%-62.76M |
| Net non-operating interest income expense | 37.14%29.66M | 26.96%7.51M | 42.59%8.38M | 51.65%8.07M | 26.29%5.69M | 227.14%21.63M | 75.89%5.92M | 149.89%5.88M | 663.56%5.32M | 2,188.32%4.51M |
| Non-operating interest income | 37.14%29.66M | 26.96%7.51M | 42.59%8.38M | 51.65%8.07M | 26.29%5.69M | 227.14%21.63M | 75.89%5.92M | 149.89%5.88M | 663.56%5.32M | 2,188.32%4.51M |
| Other net income (expense) | 1.00%-199K | 105.13%6K | 65.77%-89K | -204.35%-72K | -141.12%-44K | -100.07%-201K | -139.26%-117K | -260K | -99.98%69K | 107K |
| Special income (charges) | --0 | --0 | --0 | ---- | ---- | -100.16%-440K | --0 | ---440K | ---- | ---- |
| -Less:Impairment of capital assets | --0 | --0 | --0 | ---- | ---- | --440K | --0 | --440K | ---- | ---- |
| Other non- operating income (expenses) | -183.26%-199K | 105.13%6K | -149.44%-89K | -204.35%-72K | -141.12%-44K | 319.30%239K | -139.26%-117K | --180K | 128.63%69K | --107K |
| Income before tax | 1.04%-167.46M | -19.77%-47.53M | -3.51%-40.56M | -30.47%-42.03M | 35.78%-37.34M | -211.83%-169.22M | -37.10%-39.69M | -42.94%-39.18M | -113.41%-32.21M | -79.12%-58.14M |
| Income tax | 100.83%117K | -133.53%-14.12M | ||||||||
| Net income | -8.04%-167.58M | -86.39%-47.65M | -3.51%-40.56M | -30.47%-42.03M | 35.78%-37.34M | -242.04%-155.1M | 5.63%-25.56M | -57.42%-39.18M | -118.51%-32.21M | -350.99%-58.14M |
| Net income continuous Operations | -8.04%-167.58M | -86.39%-47.65M | -3.51%-40.56M | -30.47%-42.03M | 35.78%-37.34M | -242.04%-155.1M | 5.63%-25.56M | -57.42%-39.18M | -118.51%-32.21M | -350.99%-58.14M |
| Minority interest income | 90.10%-192K | 0 | 0 | 0 | -7.26%-192K | 3.96%-1.94M | -475.16%-1.76M | 0 | 0 | 77.46%-179K |
| Net income attributable to the parent company | -9.28%-167.38M | -100.17%-47.65M | -3.51%-40.56M | -30.47%-42.03M | 35.91%-37.15M | -237.72%-153.16M | 11.12%-23.8M | -57.97%-39.18M | -118.42%-32.21M | -379.10%-57.96M |
| Preferred stock dividends | ||||||||||
| Other preferred stock dividends | ||||||||||
| Net income attributable to common stockholders | -9.28%-167.38M | -100.17%-47.65M | -3.51%-40.56M | -30.47%-42.03M | 35.91%-37.15M | -237.72%-153.16M | 11.12%-23.8M | -57.97%-39.18M | -118.42%-32.21M | -379.10%-57.96M |
| Basic earnings per share | 13.40%-2.78 | -1,116.67%-0.73 | 24.18%-0.69 | 8.54%-0.75 | 39.44%-0.86 | -230.49%-3.21 | 89.83%-0.06 | -68.52%-0.91 | -121.03%-0.82 | -425.93%-1.42 |
| Diluted earnings per share | 13.40%-2.78 | -1,116.67%-0.73 | 24.18%-0.69 | 8.54%-0.75 | 39.44%-0.86 | -234.87%-3.21 | 89.83%-0.06 | -68.52%-0.91 | -121.75%-0.82 | -425.93%-1.42 |
| Dividend per share | ||||||||||
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |
Trending Stocks
Discussing
As China's 'two sessions' commence: How will Chinese stocks perform?
🎙️Discussion 1. With the government's emphasis on technological innovation and sustainability, which industry sectors do you believe hold t
Moomoo News Global
Mar 4 23:26
China's Two Sessions: Key Takeaways on Stock Price Movements Before and After the Meetings